# DESCRIPTION

## FIELD OF THE INVENTION

- relate to therapeutics

## BACKGROUND OF THE INVENTION

- motivate PTSD
- discuss NAc and epigenetic mechanisms
- summarize prior studies on PTSD and DNA methylation

## SUMMARY OF THE INVENTION

- describe PTSD rat model and discoveries

## DETAIL DESCRIPTIONS OF THE INVENTION

- describe PTSD model in rats

### Embodiment 1. DNA Methylation Profiles of PTSD Susceptibility and Resilience in a Rat Model of PTSD

- describe animal selection and housing
- outline behavioral procedure
- detail habituation process
- describe baseline measurement
- outline initial exposure to stress
- describe first and second reminders
- detail behavioral measurements
- analyze behavioral data
- describe PTSD-like behaviors and resilience
- collect tissue samples

### Embodiment 2. Reversal of Two PTSD Behaviors, Exploration and Social Interaction by SAM Treatment

- motivate SAM treatment for PTSD
- describe SAM treatment effects on behavioral parameters
- analyze DNA methylation profile changes with SAM treatment

### Embodiment 3. Discovery of “Upstream Regulators” of Genes that are Differentially Methylated in Susceptible and Resilient Traumatized Animals and Reversed by SAM Treatment

- identify upstream regulators of differentially methylated genes

### Embodiment 4. Reversal of All Three Characteristic Pathological Behaviors of PTSD with a Novel Combination of Retinoic Acid and SAM

- test combination of SAM and retinoic acid for reversing PTSD behaviors

## Applications of the Present Invention

- introduce PTSD therapeutics and drug discovery
- motivate epigenetic mechanisms in PTSD
- describe animal model for PTSD
- summarize DNA methylation alterations in PTSD
- show resilient animals' DNA methylation response
- correlate individual behavioral phenotypes with DNA methylation
- describe SAM's treatment effects on DNA methylation and behavior
- identify retinoic acid pathway as a target for PTSD treatment
- summarize combination therapy approach for PTSD treatment

